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Abstract. 
 
The Src-related tyrosine kinase p56
 
lck
 
 (Lck) 
is primarily expressed in T lymphocytes where it local-
izes to the cytosolic side of the plasma membrane and 
associates with the T cell coreceptors CD4 and CD8. As 
a model for acylated proteins, we studied how this lo-
calization of Lck is achieved. We followed newly syn-
thesized Lck by pulse–chase analysis and found that 
membrane association of Lck starts soon after synthe-
sis, but is not complete until at least 30–45 min later. 
Membrane-binding kinetics are similar in CD4/CD8-
positive and CD4/CD8-negative cells. In CD4-positive 
T cells, the interaction with CD4 rapidly follows mem-
brane association of Lck. Studying the route via which 
Lck travels from its site of synthesis to the plasma 
membrane, we found that: CD4 associates with Lck 
within 10 min of synthesis, long before CD4 has 
reached the plasma membrane; Lck associates with in-
tracellular CD4 early after synthesis and with cell sur-
face CD4 at later times; and transport of CD4-bound 
Lck to the plasma membrane is inhibited by Brefeldin 
A. These data indicate that the initial association of 
newly synthesized Lck with CD4, and therefore with 
membranes, occurs on intracellular membranes of the 
exocytic pathway. From this location Lck is transported 
to the plasma membrane.
Key words: p56
 
lck
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A
 
CYLATION
 
, the covalent attachment of fatty acids, is a
modification that allows numerous cytosolic pro-
teins to associate with the cytoplasmic leaflet of
cellular membranes (Resh, 1994; Milligan et al., 1995;
Wedegaertner et al., 1995; Bhatnagar and Gordon, 1997).
Acylated proteins have specific subcellular localizations
that are important for their functions, but very little is
known about the mechanisms involved in targeting these
proteins to specific sites in the cell. To obtain more insight
into this, we are studying the acylated tyrosine kinase
 
p56
 
lck
 
 (Lck).
 
1
 
Lck is a member of the Src-family of nonreceptor ki-
nases and is expressed primarily in T lymphocytes and thy-
mocytes. The protein is predominantly associated with the
cytosolic side of the plasma membrane (Ley et al., 1994;
Bijlmakers et al., 1997), a localization that is consistent
with the importance of Lck in the early signaling events
through the T cell receptor (TcR) (Weiss and Littman,
1994). The domain organization of Lck is identical to that
of other Src-family kinases (Fgr, Hck, Blk, Fyn, Lyn, Yes,
Src, Yrk) (Rudd et al., 1993). Each possesses a conserved
Src-homology 2 (SH2), SH3, and kinase domain, while the
NH
 
2
 
-terminal 50–70 amino acids (the unique domain) are
unique to each individual member. Src-related kinases are
modified by the attachment of myristic acid to an NH
 
2
 
-ter-
minal glycine and, with the exception of Src and Blk, con-
tain potential palmitoylation sites as well (Resh, 1994; Mil-
ligan et al., 1995). The short conserved NH
 
2
 
-terminal
region that contains the acylation sites has been desig-
nated the SH4 domain (Resh, 1993). Despite the similarity
between members of the Src-family, the subcellular distri-
bution of Lck is not identical to that of its relatives. Many
Src-related proteins localize to the plasma membrane but
are also found at other locations in the cell: v-Src in focal
adhesions (Rohrschneider, 1980), c-Src on endosomes
(Kaplan et al., 1992) and synaptic vesicles (Linstedt et al.,
1992), Fyn in the microtubule organizing center (Ley et al.,
1994), and Hck on secretory granules (Mohn et al., 1995).
One feature that distinguishes Lck from other members
of the Src-family is its association with the cytoplasmic do-
mains of the cell surface proteins CD4 and CD8 (Rudd
et al., 1988; Veillette et al., 1988), coreceptors of the TcR
on helper and cytotoxic T cells, respectively. However, this
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noncovalent interaction, mediated by a pair of cysteines
(C20 and C23) in the unique domain of Lck and a CXCP
motif in the cytoplasmic tails of CD4 or CD8
 
a
 
 (Shaw et al.,
1990; Turner et al., 1990), is not required to target Lck to
the plasma membrane (Bijlmakers et al., 1997). Rather,
we observed that the unique domain of Lck contains
plasma membrane targeting information that can operate
in the absence of coreceptor expression (Bijlmakers et al.,
1997). The identity of these targeting signal(s) and their
mode of operation remain to be established.
In this study we investigated the route via which Lck
travels to the plasma membrane. Two extreme possibilities
can be envisaged: Lck could insert directly into the plasma
membrane after synthesis. Alternatively, the newly syn-
thesized protein could initially be targeted to intracellular
membranes and subsequently travel to the plasma mem-
brane. Lck is myristoylated during translation (Paige et al.,
1993), but stable association with membranes requires
posttranslational palmitoylation (Kwong and Lublin, 1995).
Palmitoyl transferases are membrane-associated enzymes
and there is evidence for their presence at the plasma
membrane (Dunphy et al., 1996; Schroeder et al., 1996),
intermediate compartment (Bonatti et al., 1989), and
Golgi complex (Solimena et al., 1994). However, it is not
yet known where the palmitoylation, and therefore the ini-
tial membrane association, of Lck occurs.
We followed newly synthesized Lck by pulse–chase
analysis in the human leukemia T cell line SupT1 and es-
tablished membrane- and CD4-binding kinetics. We ob-
served that a large proportion of Lck is not targeted to the
plasma membrane directly, but initially associates with in-
tracellular membranes and is subsequently transported to
the plasma membrane in a Brefeldin A (BFA)-sensitive
manner. Our data describe a novel pathway for the traf-
ficking of a newly synthesized acylated cytosolic protein.
 
Materials and Methods
 
Reagents
 
Tissue culture reagents and plastics were from Gibco Ltd. and other
chemicals were from Sigma Chemical Co., unless indicated otherwise.
 
Cell Lines and Antibodies
 
The human T cell line SupT1 and Jurkat cells were cultured in RPMI 1640
supplemented with 10% FCS, 100 U/ml penicillin, 0.1 mg/ml streptomycin
(pen/strep). The mutant Jurkat cell line JCam.1 was provided by A. Weiss
(University of California, San Francisco, CA). These cells express low lev-
els of a shorter mutant form of Lck, but not wild-type (wt) Lck (Straus
and Weiss, 1992). NIH-3T3 cells stably transfected with human Lck (Bijl-
makers et al., 1997) were cultured in DMEM, 10% FCS, pen/strep, 1 mg/ml
G418.
Two polyclonal rabbit anti-Lck sera, here designated LckN and LckC,
were used. LckN (Brouns et al., 1993) was provided by J. Borst (The
Netherlands Cancer Institute, Amsterdam, The Netherlands) and used in
immunoprecipitation experiments. This serum was raised against an NH
 
2
 
-
terminal Lck peptide comprising residues 39–58. In addition to Lck, LckN
also immunoprecipitates and immunoblots an unidentified protein with a
slightly higher molecular weight than Lck (Fig. 1). LckC (Ley et al., 1994),
provided by S. Ley (National Institute for Medical Research, Mill Hill,
United Kingdom), was used in Western blotting. This antibody was raised
against a synthetic Lck peptide comprising residues 478–509. For immuno-
precipitation of CD4, a mixture of two mouse mAbs, #4 and #19, provided
by J. Hoxie (University of Philadelphia, Philadelphia, PA) was used. The
anti-CD4 mouse mAb Q4120 was used for immunoblotting. Peroxidase-
conjugated goat anti–rabbit antibodies were from Pierce and Warriner.
 
Pulse–Chase Labeling
 
Cells were washed once and incubated for 45 min in methionine- and cys-
teine-free DME medium (ICN Biomedicals Ltd.). For pulse-labeling of
suspension cells (SupT1 and Jurkat cells), typically 1 mCi [
 
35
 
S]methionine/
cysteine (Express [1,175 Ci/mmol]; DuPont) was used per 10
 
8
 
 cells in 1 ml
methionine- and cysteine-free DME medium, 10% FCS. When chase
times did not exceed 15 min, incorporation of label was terminated by the
addition of nonradioactive methionine and cysteine to a final concentra-
tion of 1 mM each. For experiments with chase times 
 
.
 
15 min, cells were
transferred after the pulse to 10 ml warm (37
 
8
 
C) DMEM with methionine
and cysteine at a final concentration of 1 mM. Where indicated, BFA was
present at a final concentration of 10 
 
m
 
g/ml (added from a 2.5 mg/ml stock
in EtOH) before and during the pulse, and at 2 
 
m
 
g/ml during the chase.
Samples taken at indicated chase times were kept in 10 ml ice-cold
DMEM until the final time point, pelleted by centrifugation (5 min at
1,500 rpm, 4
 
8
 
C), and further processed as described for individual experi-
ments. For the adherent NIH-3T3 cells, per time point one 10-cm dish of
cells (
 
z
 
7 
 
3
 
 10
 
6
 
) was labeled with 0.75 mCi [
 
35
 
S]methionine/cysteine in 1
ml methionine- and cysteine-free DME medium without FCS. The chase
was started by replacing the radiolabel with prewarmed DMEM contain-
ing cysteine and methionine at 1 mM each. At the end of the chase this
medium was replaced by ice-cold DMEM. The cells were put on ice, gently
scraped, and recovered by centrifugation at 1,500 rpm for 5 min at 4
 
8
 
C.
 
Immunoprecipitation, Endoglycosidase H (Endo H) 
Digestion, and Gel Electrophoresis
 
Unless indicated otherwise, cells were lysed in NP-40 buffer (2% NP-40
[Pierce and Warriner], 20 mM Tris, pH 7.8, 150 mM NaCl, 2 mM MgCl
 
2
 
,
1 mM EDTA) containing the protease inhibitors PMSF (at 1 mM) and
CLAP (5 
 
m
 
g/ml each of chymostatin, pepstatin A, antipain hydrochloride,
and 10 
 
m
 
g/ml leupeptin hemisulphate). After removal of nuclei and cell
debris by centrifugation at 13,000 
 
g
 
 for 5 min at 4
 
8
 
C, the lysates were
cleared of nonspecifically binding proteins by three rounds of incubations
with normal rabbit serum (3 
 
m
 
l) and 20 
 
m
 
l packed protein A–Sepharose
beads (Pharmacia Biotech AB) for 30 min at 4
 
8
 
C. For specific immuno-
precipitations, samples were incubated on ice for 45 min with relevant an-
tibodies: 1 
 
m
 
l of the polyclonal rabbit serum LckN for immunoprecipita-
tion of Lck or a mixture of mAbs #4 (1.7 
 
m
 
g) and #19 (0.5 
 
m
 
g) for CD4.
Immune complexes were recovered by incubation with protein A–Seph-
arose (25 
 
m
 
l packed beads) for 45 min at 4
 
8
 
C and washed five times in
NP-40 lysis buffer. For Endo H digestion, washed immunoprecipitates
were incubated for 1 h at 37
 
8
 
C with 1 mU Endo H (Boehringer Mann-
heim) in 50 mM sodium citrate (pH 5.5), 0.02% SDS. Immune complexes
were eluted by addition of nonreducing SDS sample buffer, incubated for
5 min at 95
 
8
 
C, and loaded on 8% SDS-polyacrylamide gels. After electro-
phoresis, gels were enhanced in salicylic acid (16% wt/vol in 30% metha-
nol), dried, and exposed to Kodak X-Omat AR film (Eastman Kodak
Co.) for 1–9 d.
 
Immunoblotting
 
After gel electrophoresis, proteins were transferred to nitrocellulose
membranes (Schleicher and Schuell). The blots were incubated in block-
ing buffer (10% skimmed milk, 0.1% Tween 20 in PBS) for 1 h at room
temperature. Incubations with primary and secondary antibodies were in
blocking buffer for 1 h each at room temperature. To detect Lck, the rab-
bit antiserum LckC (1:1,000) and HRP-conjugated goat anti–rabbit anti-
bodies (1:2,000) were used. Q4120 (1.6 
 
m
 
g/ml) and HRP-conjugated goat
anti–mouse antibodies (1:2,000) were used to detect CD4. Blots were de-
veloped using enhanced chemiluminescence (Amersham International
plc) and visualized with autoradiography film (Fuji Photo Film Co. Ltd.).
 
Membrane Separation
 
After pulse–chase labeling, cells were incubated in 1 ml hypotonic buffer
(20 mM Tris, pH 7.8, 2 mM MgCl
 
2
 
, 1 mM EDTA, 1 mM PMSF, CLAP as
above) on ice for 12 min and homogenized by 15 strokes in a Dounce ho-
mogenizer (Wheaton Scientific). To remove nuclei, cell homogenates
were centrifuged for 5 min at 1,500 rpm, 4
 
8
 
C. The postnuclear supernatant
was centrifuged in an Optima TL Ultracentrifuge (Beckman Instruments)
for 45 min at 100,000 
 
g
 
, 4
 
8
 
C, to recover total cellular membranes. The pel-
let (membrane fraction) was resuspended in hypotonic buffer, Dounce ho-
mogenized (20 strokes), and adjusted to 2% NP-40, 150 mM NaCl, 1 mM
PMSF, and CLAP. Similarly, the soluble fractions were adjusted to 2% 
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NP-40 and 150 mM NaCl. The final volume of both fractions was equiva-
lent. Samples (2% of total volume) were analyzed by immunoblotting to
check the efficiency of membrane separation and the remainder was sub-
jected to immunoprecipitation. In control experiments, to examine the
presence of Lck in the nuclear fraction, nuclei were resuspended in an
equal volume of the same buffer as the membrane and soluble fractions
and analyzed for Lck by immunoprecipitation and immunoblotting. The
amount of Lck detected in this fraction was negligible (Fig. 2 A).
 
Sequential Immunoprecipitations of Cell Surface and 
Intracellular CD4
 
After pulse–chase labeling, SupT1 cells (2.5 
 
3
 
 10
 
7
 
 for each time point)
were washed once with ice-cold DMEM and incubated with the anti-CD4
antibodies #4 (1.7 
 
m
 
g/ml) and #19 (0.5 
 
m
 
g/ml) for 1 h at 4
 
8
 
C to absorb cell
surface CD4. During incubation, the cells were kept in suspension by rota-
tion. The cells were washed three times with 10 ml ice-cold DMEM to re-
move unbound antibody. Next, the cells were lysed in NP-40 buffer (see
above) to which soluble nonlabeled CD4 (150 ng/ml, diluted from a 500
 
m
 
g/ml stock; American Biotechnologies) was added to prevent binding of
intracellular labeled CD4 to free antigen-binding sites. Nuclei and cell de-
bris were removed by centrifugation (5 min at 13,000 
 
g
 
, 4
 
8
 
C) and cell sur-
face CD4 was recovered by incubation with 25 
 
m
 
l packed protein A–Seph-
arose beads. To recover the remaining intracellular CD4, the lysate was
precleared twice with normal rabbit serum and protein A–Sepharose and
subsequently incubated with antibodies #4 and #19 and protein A–Seph-
arose again.
 
Quantitation
 
Autoradiograms were digitized using Sony XC-77CE CCD video camera
and NIH Image, stored as TIFF files and imported into the Bio-Rad Mo-
lecular Analyst program for analysis. The relative amount of membrane-
associated Lck (Figs. 2–4) was determined as follows: [
 
M
 
 
 
2
 
 
 
BG1
 
/(
 
M
 
 
 
2
 
BG1
 
) 
 
1
 
 (
 
S
 
 
 
2
 
 
 
BG2
 
)] 
 
3
 
 100%, where M is the density of the membrane-
associated Lck band, BG1 the background in the membrane lane, S the
density of the soluble Lck band, and BG2 the background in the soluble
fraction. The relative amount of CD4-associated Lck (Fig. 5 A) was deter-
mined as follows: [
 
CD4
 
 
 
2
 
 
 
BG1
 
/(
 
CD4
 
 
 
2
 
 
 
BG1
 
) 
 
1
 
 (
 
Lck
 
 
 
2
 
 
 
BG2
 
)] 
 
3
 
 100%,
with CD4 being the density of the Lck band in the anti-CD4 immunopre-
cipitation, and BG1 the background in the anti-CD4 immunoprecipita-
tion; Lck the density of the Lck band in the anti-Lck immunoprecipita-
tion, and BG2 the background in the anti-Lck immunoprecipitation. The
relative amount of Lck associated with cell surface CD4 (Fig. 8) was de-
termined as follows [
 
Lck
 
(
 
CS
 
) 
 
2
 
 
 
BG1
 
/{
 
Lck
 
(
 
CS
 
) 
 
2
 
 
 
BG1
 
} 
 
1
 
 {
 
Lck
 
(
 
IC
 
) 
 
2
 
BG2
 
}] 
 
3
 
 100%, where Lck(CS) is the density of the Lck band in the im-
munoprecipitation of cell surface CD4, Lck(IC) the density of the Lck
band in the immunoprecipitation of intracellular CD4, and BG1 and BG2
the background in cell surface and intracellular immunoprecipitation, re-
spectively. The relative amount of CD4 at the plasma membrane was de-
termined in the same way for the CD4 bands. We found that quantitation
of autoradiograms leads to an overestimation of signals with low intensity,
as a result of which curves do not reach the 0 and 100% as would be ex-
pected based on the autoradiograms. Similar curves were obtained when
the gels were analyzed using a PhosphorImager.
 
Results
 
Membrane-Association Kinetics of Lck
 
We used the human leukemia T cell line SupT1 to study
the mechanism by which newly synthesized Lck reaches
the plasma membrane. In these cells, the majority of Lck is
detected at the cytosolic side of the plasma membrane by
immunofluorescence (Bijlmakers et al., 1997). In the study
described here, we used pulse–chase labeling and immu-
noprecipitation to follow newly synthesized Lck. The rab-
bit antiserum used for immunoprecipitations (Brouns et al.,
1993) recognizes Lck and, in addition, a protein with a
slightly higher molecular weight. Lck was identified by
comparing Jurkat cells that express wt Lck, with JCam.1
cells, a Jurkat derivative that expresses very low levels of a
 
shorter, mutant Lck (Fig. 1 A). The background band was
detected in both cell lysates whereas wt Lck was only de-
tected in Jurkat lysates (the shorter mutant Lck in JCam.1
was only visible after long exposures of the autoradio-
gram, not shown). The background band (marked with 
 
w
 
)
was also detected in a variety of Lck-negative cell lines in-
cluding HeLa and NIH-3T3 (not shown), indicating that
this protein is not associated with, nor related to, Lck. Lck
was further identified by its association with CD4 in
SupT1 cells. Lck and CD4 have similar molecular weights;
however, in SDS-PAGE, under nonreducing conditions,
CD4 migrates slightly faster than Lck and the two proteins
can be clearly resolved. Immunoprecipitation with anti-
CD4 antibodies resulted in coimmunoprecipitation of Lck,
but not of the background band (Fig. 1 B). Vice versa, im-
munoprecipitation with anti-Lck antibodies coimmuno-
precipitated CD4. As expected, CD4 only coimmuno-
precipitated from a membrane, but not from a soluble
fraction (Fig. 1 B).
To establish the kinetics with which newly synthesized
Lck becomes membrane-associated, SupT1 cells were
pulse-labeled for 5 min with [
 
35
 
S]methionine/cysteine and
chased for various times. The cells were then broken in hy-
potonic buffer, the nuclei removed by centrifugation, and
total cellular membranes recovered by centrifugation at
100,000 
 
g
 
. By immunoblotting, total cellular Lck was de-
tected exclusively in the membrane fraction (Fig. 2 A), in-
dicating that virtually all Lck is membrane-associated at
steady state. To study newly synthesized labeled mole-
cules, Lck was immunoprecipitated from the membrane
and soluble fractions and analyzed by SDS-PAGE. After 5
min of pulse-labeling only a small amount of Lck (
 
z
 
15%)
was found at membranes (Fig. 2 B). This amount in-
creased with time, and membrane association was com-
Figure 1. Characterization of Lck antiserum. (A) Jurkat (wt) and
mutant JCam.1 (D) cells (6 3 106 each) were labeled for 30 min
with [35S]methionine/cysteine (0.5 mCi) and subjected to immu-
noprecipitation with LckN serum. JCam.1 does not express wt
Lck (Straus and Weiss, 1992). In addition to Lck, the LckN anti-
serum recognizes a protein with an apparent molecular mass of
60 kD (w). (B) SupT1 cells were labeled with [35S]methionine/
cysteine for 5 min and chased for 15 min. Cells were broken in
hypotonic buffer, nuclei removed by centrifugation, and mem-
branes recovered by centrifugation at 100,000 g for 45 min. Mem-
brane and soluble fractions were split into two: half was subjected
to immunoprecipitation with anti-CD4 antibodies (aCD4), the
other half with anti-Lck antibodies (aLck). The CD4 immuno-
precipitation from membranes, and the Lck immunoprecipitation
both from the membrane (M) and soluble (S) fractions are
shown. CD4, Lck, and the background band (w) are indicated. 
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plete after 30–45 min of chase (Fig. 2 B). Newly synthe-
sized CD4 coimmunoprecipitated with Lck already at
early chase times (5 min), and, as expected, was only de-
tected in membrane fractions (Fig. 2 B). This coimmuno-
precipitation was easier to detect when cells were directly
lysed in NP-40 buffer (see Fig. 6). Quantitation showed
that the kinetics of Lck membrane association were con-
sistent between experiments and occurred with a calcu-
lated half time of 9 min.
 
Membrane-Binding Kinetics of Lck in the Absence of 
CD4/CD8 Interaction
 
In SupT1 cells, the majority of Lck (at least 70%) is associ-
ated with CD4, as determined by coimmunoprecipitation
experiments (not shown). However, this interaction is not
essential for membrane binding of Lck, since also in CD4/
CD8-negative T cells, Lck is completely membrane-associ-
ated at steady state (Bijlmakers et al., 1997). Nevertheless,
CD4 or CD8 could influence the rate of membrane bind-
ing of newly synthesized Lck. To examine this, we studied
Lck membrane binding in BC7 cells, a CD4-negative de-
rivative of SupT1. The kinetics of membrane association
were identical to those seen in SupT1 cells (not shown), in-
dicating that membrane recruitment of Lck is not depen-
dent on the presence of CD4. However, BC7 and SupT1
cells do express CD8, and therefore a role for this protein
could not be excluded, although an interaction with CD8
was not observed by immunoprecipitation.
Therefore, we also determined Lck membrane-binding
kinetics in the CD8-negative Jurkat cells. Three different
Jurkat clones were screened by FACS
 
®
 
 analysis for CD4
expression. Two were found to express very little if any
CD4, whereas one expressed considerable amounts of
CD4 (approximately half the amount of CD4 in SupT1
cells, which is 
 
z
 
30,000 copies per cell; Pelchen-Matthews
et al., 1991). This was confirmed by immunoblotting (Fig.
3 C). Again, we did not find a difference in membrane as-
sociation of newly synthesized Lck between CD4-positive
and -negative cells (Fig. 3, A, B, and D). However, mem-
brane-binding kinetics of Lck were slower in Jurkat cells
than in SupT1 cells (
 
t
 
1/2
 
 21 min in Jurkat vs. 9 min in
SupT1), indicating that cell type–specific differences can
influence these kinetics.
The membrane-binding kinetics measured here for Lck
differ from those reported recently for another member of
the Src-family, Fyn (van’t Hof and Resh, 1997), which is
also myristoylated and palmitoylated. Membrane binding
of Fyn was studied in transfected NIH-3T3 fibroblasts and
COS cells and found to be complete within 5 min of syn-
thesis. To investigate whether this apparent difference
between Lck and Fyn was due to the different cellular
backgrounds, we also analyzed Lck in stably transfected
NIH-3T3 cells. Previously, we established that at steady
state all the Lck is membrane bound in these cells (Bijlmak-
ers et al., 1997). We found little Lck on membranes after 5
min of labeling, whereas membrane association of newly
synthesized Lck proceeded at rates similar to those seen in
SupT1 cells, with 50% membrane-associated after 10 min
(Fig. 4, A and B). Thus, T cell–specific proteins do not en-
hance membrane binding of newly synthesized Lck and
Lck differs markedly from Fyn in its rate of membrane as-
sociation.
 
Kinetics of Lck Association with CD4
 
In mammalian cells, nonpalmitoylated soluble Lck does
not interact with CD4 (Turner et al., 1990), suggesting that
membrane binding of Lck is necessary for stable associa-
tion with CD4. To establish the kinetics of CD4 interac-
tion, SupT1 cells were pulse-labeled and chased, and cell
lysates were then subjected to sequential immunoprecipi-
tations, first with anti-CD4 antibodies and then with anti-
Lck antibodies. With the anti-CD4 antibodies we recov-
Figure 2. Membrane-binding ki-
netics of Lck. (A) SupT1 cells
were broken in hypotonic buffer
and Dounce homogenized. Af-
ter removal of nuclei (5 min at
1,500 rpm), membrane and solu-
ble fractions were separated by
centrifugation at 100,000 g.
Equivalent amounts of total (T),
nuclear (N), membrane (M),
and soluble (S) fractions were
analyzed by immunoblotting
with LckC. (B) SupT1 cells (2 3
108) were labeled with [35S]me-
thionine/cysteine (2 mCi) for 5
min and chased for the indicated
times. Lck was immunoprecipi-
tated from the membrane (M)
and soluble (S) fractions with
LckN and analyzed by SDS-
PAGE and autoradiography.
Lck and CD4 are indicated. w
indicates the background band. 
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ered CD4 and Lck and, in addition, a background band
with a molecular weight similar to the one seen in Lck im-
munoprecipitates (Fig. 5, A and C). The latter band (
 
w
 
)
was also present in the normal rabbit serum control (Fig. 5
C), showing that it is precipitated nonspecifically. In con-
trast to the anti-Lck immunoprecipitates, the background
band is not consistently found in anti-CD4 immunoprecip-
itates (see Figs. 1 B and 7 for example).
Directly after 5 min of pulse-labeling, some Lck coim-
munoprecipitated with CD4, while at 15 min chase 
 
z
 
50%
interacted with CD4 (Fig. 5 A, CD4.1 vs. Lck lanes). Previ-
ously, we determined that in SupT1 cells, at least 70% of
the total Lck is associated with CD4 at steady state. This
situation is apparently reached 60 min after synthesis (Fig.
5 A). The kinetics of the interaction with CD4 are similar
to those seen for membrane association of Lck, suggesting
that the two processes are closely linked.
We next labeled the cells for only 2 min to detect the
earliest membrane and CD4 association of Lck. On long
exposures of autoradiograms, a small amount of Lck can
be seen associated with membranes directly after the 2-min
pulse (Fig. 5 B). Association of Lck with CD4, by contrast,
can be detected only after a 3-min chase (Fig. 5 C), with a
further increase in both the amounts of membrane- and
CD4-associated Lck after a 6-min chase. Thus, membrane
association of Lck starts soon after synthesis and is rapidly
followed by CD4 association. Note that in these experi-
ments, all the CD4 is immunoprecipitated and therefore
no distinction can be made between Lck binding to newly
or previously synthesized CD4.
 
CD4 Associates with Lck Early after Synthesis
 
To determine at which time after synthesis CD4 associates
with Lck, we followed the coimmunoprecipitation of la-
beled CD4 with anti-Lck antibodies. CD4 was detected in
Lck immunoprecipitates already at 5-min chase after 5
min of pulse-labeling, and possibly even at 0-min chase
(Fig. 6 A). This is similar to the CD4 coimmunoprecipita-
tion with Lck in membrane fractions shown in Fig. 2 B.
Human CD4 carries two N-linked oligosaccharides (Konig
et al., 1988), one of which becomes resistant to Endo H, an
enzyme that selectively removes high mannose N-linked
oligosaccharides (Crise and Rose, 1992b). Endo H resis-
tance is acquired when the protein is delivered to the cis-
Golgi where trimming of the high mannose carbohydrate
occurs. Directly after pulse-labeling and at 5 min of chase,
the majority of CD4 is Endo H–sensitive, indicating that
the protein has not yet reached the cis-Golgi (Fig. 6 B).
Endo H–resistant CD4 first appeared at 10 and 15 min of
chase and coincided with a decrease in the amount of
Endo H–sensitive CD4 (Fig. 6 B). We also detected small
amounts of Endo H–sensitive CD4 in Lck immunoprecipi-
tates at 5 min of chase (not shown). Together, the data
Figure 3. Lck membrane-binding kinetics in the presence and absence of CD4. (A) CD4-negative Jurkat cells were labeled for 5 min
and chased as indicated. Lck was immunoprecipitated from membrane (M) and soluble (S) fractions as described for Fig. 2 B. w indi-
cates the background band. (B) The same experiments as in A, now for CD4-positive Jurkat cells. (C) Cell lysates of CD4-negative (2)
and CD4-positive (1) Jurkat cells were analyzed for CD4 expression by immunoblotting. (D) Quantitation of Lck membrane-binding
experiments for two CD4-negative and one CD4-positive Jurkat cell line. Autoradiograms were digitized (as described in Materials and
Methods) and analyzed using the Molecular Analyst program (Bio-Rad). Membrane-associated Lck is expressed as a percentage of the
total amount of Lck and plotted against time.The Journal of Cell Biology, Volume 145, 1999 462
show that CD4 interacts with Lck early after synthesis,
possibly on the ER or intermediate compartment.
Shortly after Synthesis, Lck Associates Predominantly 
with Intracellular CD4
The previous experiment indicates that CD4 associates
with Lck early in the exocytic pathway; however, this ex-
periment does not discriminate between association of
CD4 with newly or previously synthesized Lck. To deter-
mine the route through which Lck traffics to the plasma
membrane, it is necessary to follow the pool of newly syn-
thesized Lck exclusively. Therefore, we investigated the
arrival of Lck at the plasma membrane at various times af-
ter pulse-labeling by selectively immunoprecipitating cell
surface CD4. For this purpose, intact SupT1 cells were in-
cubated with anti-CD4 antibodies on ice, thereby ensuring
that only cell surface CD4 was complexed with antibody.
Next the cells were lysed in the presence of soluble unla-
beled CD4 to prevent binding of intracellular labeled CD4
to antibodies during lysis. Cell surface CD4 was then iso-
lated by incubation with protein A–Sepharose. Intracellu-
lar CD4 was subsequently recovered by a second round of
immunoprecipitation with anti-CD4 antibodies. In agree-
ment with reported transport rates of CD4 (Crise and
Rose, 1992b), we observed that at 0, 10, and 20 min of
chase, the majority of newly synthesized CD4 was found
inside the cell (Fig. 7). Approximately 50% was at the cell
surface after 40 min of chase and at 90 min the majority
was at the cell surface. At 0 min of chase, CD4 is com-
pletely Endo H–sensitive (Fig. 6 B) and has therefore not
yet reached the cis-Golgi. Therefore, the small amount of
labeled CD4 in the cell surface immunoprecipitation at
this time most likely reflects an incomplete block of free
antibody-binding sites during cell lysis and, consequently,
the recovery of some intracellular CD4. A similar explana-
tion accounts for the small amount of labeled CD4 in the
cell surface immunoprecipitation at 10 and 20 min of
chase.
Like CD4, newly synthesized Lck can be seen to move
from the intracellular to the plasma membrane fraction
with time. Lck predominantly associated with intracellular
CD4 at early time points (0, 10, and 20 min of chase), while
the majority was associated with cell surface CD4 at 40
and 90 min of chase (Fig. 7). Thus, it appears that the ini-
tial association between newly synthesized Lck and CD4
occurs on intracellular membranes and that Lck is subse-
quently transported to the plasma membrane. Little if any
newly synthesized Lck associates directly with CD4 at the
plasma membrane although .95% of the total amount of
CD4 is located at this site. Given our observation that
binding of Lck to CD4 occurs very rapidly after membrane
Figure 4. Lck membrane-binding kinetics in NIH-3T3 cells. (A) NIH-3T3 cells stably transfected with Lck were pulse-labeled and
chased as indicated and Lck was immunoprecipitated from the membrane (M) and soluble (S) fractions. w indicates the background
band. (B) Comparison of Lck membrane-binding kinetics in SupT1 and NIH-3T3 cells. The experiments shown here and in Fig. 2 B
were quantitated. The percentage of membrane-associated Lck is plotted against time.Bijlmakers and Marsh Trafficking of p56lck 463
binding (Fig. 5, B and C), the initial membrane association
of Lck most likely occurs at the same intracellular site as
CD4 binding.
BFA Blocks Transport of CD4-associated Lck
The transfer of newly synthesized Lck from intracellular
membranes to the plasma membrane with time suggests
that CD4-associated Lck is transported via the exocytic
pathway. To further investigate this, we studied transport
of Lck in the presence and absence of the drug BFA. BFA
causes disruption of the Golgi apparatus and blocks trans-
port from the ER and Golgi complex, but not from the
TGN to the plasma membrane (Klausner et al., 1992). The
drug was added 2 min before pulse-labeling and remained
present during the chase. We again followed transport of
Lck by its association with cell surface versus intracellular
CD4. In the absence of BFA, the amount of cell surface
CD4 increased with time (Fig. 8, A and C), while in its
presence all CD4 remained intracellular, consistent with
an inhibition of transport via the secretory pathway. Simi-
larly, the relative amount of cell surface–bound Lck at 30
and 60 min of chase was significantly reduced in the pres-
ence of BFA (Fig. 8, A and B), suggesting that the newly
synthesized Lck was associated with early compartments
of the exocytic pathway and its transport to the plasma
membrane inhibited by BFA. The block in transport
caused by BFA was not as complete for Lck as for CD4:
some Lck associated with nonlabeled cell surface CD4 at
30 and 60 min chase (Fig. 8, A and B). This minor fraction
of Lck might be targeted from its site of synthesis to the
plasma membrane directly.
CD4 synthesized in the presence of BFA coimmunopre-
cipitated with anti-Lck antibodies albeit to a lower extent
than in the absence of BFA (Fig. 9 A). This is consistent
with the notion that CD4 associates with Lck on an early
exocytic compartment.
The palmitoylation of the cytosolic proteins SNAP-25
and GAP43, but not of the alpha subunits of heterotri-
meric G proteins, was shown to be inhibited in the presence
of BFA (Gonzalo and Linder, 1998). Our data suggest that
palmitoylation of Lck is not affected by BFA since its as-
sociation with CD4 occurs normally (Fig. 8). We also stud-
ied membrane binding of Lck in the presence of BFA and
found no difference in rates compared with untreated cells
(Fig. 9 B), suggesting that Lck palmitoylation indeed oc-
curred normally. Furthermore, incorporation of [3H]pal-
mitic acid into Lck was not decreased in the presence of
BFA (not shown). Thus, the reduction in the amount of Lck
associated with cell surface CD4 in the presence of BFA
Figure 5. Kinetics of the association of Lck with CD4. (A) SupT1 cells (1.25 3 108) were labeled for 5 min with [35S]methionine/cysteine
(1.5 mCi) and chased as indicated. The cells were lysed in NP-40 buffer and subjected to sequential immunoprecipitations, first with two
rounds of anti-CD4 antibodies (CD4.1 and CD4.2) and next with anti-Lck antibodies (Lck). (B) SupT1 cells (108) were labeled with
[35S]methionine/cysteine (1 mCi) for 2 min and chased for 0, 3, or 6 min. Lck was immunoprecipitated from membrane (M) and soluble
(S) fractions with LckN and analyzed by SDS-PAGE and autoradiography. (C) SupT1 cells (7.5 3 107) were labeled with [35S]methio-
nine/cysteine (1 mCi) for 2 min and chased for 0, 3, or 6 min. Cell lysates were subjected to sequential immunoprecipitations, first with
anti-CD4 antibodies (CD4) and next with anti-Lck antibodies (Lck). The last of three rounds of preclears with normal rabbit serum
(NRS) and protein A–Sepharose is shown for the 6-min chase (NRS). Lck, CD4, and the background band (w) are indicated.The Journal of Cell Biology, Volume 145, 1999 464
(Fig. 8, A and B) is most likely caused only by the inhibi-
tion of transport through the exocytic pathway.
Discussion
To understand the mechanism(s) through which acylated
cytosolic proteins are targeted to their functional locations
in cells, we have studied the early events in the membrane
binding and cellular localization of the Src-related tyrosine
kinase Lck. We have shown previously that Lck contains
intrinsic targeting signals in its NH2-terminal unique do-
main that direct the protein to the cytosolic leaflet of the
plasma membrane (Bijlmakers et al., 1997). In the present
study we have used pulse–chase analysis to investigate
how newly synthesized Lck is delivered to this location.
Our data indicate that in the lymphoid T cell line SupT1, a
large proportion of Lck is initially targeted to an intracel-
lular compartment, most likely an early station of the exo-
cytic pathway, where it becomes stably membrane-bound
and can interact with CD4, before it is transported to the
cell surface.
Membrane binding of Lck is a relatively slow process; it
starts soon after synthesis but is not complete until 30–45
min later. An Lck mutant that cannot be palmitoylated is
unable to associate with membranes (Kwong and Lublin,
1995; Yurchak and Sefton, 1995; Bijlmakers et al., 1997;
Zlatkine et al., 1997), indicating that palmitoylation is re-
quired for stable membrane interaction of Lck. Membrane
association has similar kinetics in the presence or absence
of CD4 and CD8 (Fig. 3). Thus, the rate of membrane as-
sociation likely reflects the rate of Lck palmitoylation and
not its interaction with these transmembrane proteins.
Membrane binding has been studied for only a few acy-
lated proteins and at present it remains unclear what
elements are important for the kinetics of this process.
Between different T cell lines, we did observe slight differ-
ences in membrane-binding rates. However, all our kinet-
ics for Lck differ significantly from those measured by
others for another Src-kinase, Fyn, which is completely
membrane-bound within 5 min of synthesis (van’t Hof and
Resh, 1997). The rapid membrane association of Fyn was
shown to require myristoylation at the NH2-terminal gly-
cine and palmitoylation at cysteine 3 (van’t Hof and Resh,
1997). Significantly, both Lck and Fyn are myristoylated
and can be palmitoylated at cysteine 3 (Resh, 1994). In ad-
dition, Lck can also be palmitoylated at cysteine 5 and Fyn
at cysteine 6. Cysteine 3 was found to be the major pal-
mitoylation site for both proteins (Alland et al., 1994;
Figure 6. Kinetics of the association of CD4 with Lck. (A) SupT1 cells (5 3 107) were labeled for 5 min with [35S]methionine/cysteine
(0.5 mCi) and chased for the indicated times. The cells were lysed in NP-40 buffer and subjected to immunoprecipitation with anti-LckN
serum. Association of CD4 with Lck was detected by coimmunoprecipitation with Lck. Lck, CD4, and the background band (w) are in-
dicated. (B) SupT1 cells were labeled as described in A, lysed, and CD4 was immunoprecipitated from the cell lysates. Immunoprecipi-
tates were incubated with Endo H (1 mU) for 1 h at 378C before separation by SDS-PAGE. Endo H–sensitive (S) forms of CD4 from
which two carbohydrate chains were removed and resistant (R) forms from which only one carbohydrate chain was removed are indi-
cated. Nondigested CD4, containing two carbohydrate chains, migrates slower than Endo H–resistant CD4 (not shown). Coimmuno-
precipitated Lck is indicated and is unaffected by Endo H treatment.
Figure 7. Lck associates predominantly
with intracellular CD4 early after synthe-
sis. SupT1 cells (1.5 3 108) were labeled
with [35S]methionine/cysteine (1.5 mCi)
for 5 min and chased for the indicated
times. The intact cells were incubated with
antibodies against CD4 for 1 h at 48C. Af-
ter extensive washing, the cells were lysed
in the presence of soluble CD4 to block
free antibody-binding sites, and cell sur-
face CD4 (CS) was recovered by incuba-
tion with protein A–Sepharose. Subse-
quently, anti-CD4 antibodies were added
to the lysates to recover intracellular CD4
(IC). CD4 and coimmunoprecipitated Lck
are indicated.Bijlmakers and Marsh Trafficking of p56lck 465
Shenoy-Scaria et al., 1994; Yurchak and Sefton, 1995), al-
though a conflicting report exists for Lck (Rodgers et al.,
1994). Ostensibly, the modifications appear similar for the
two proteins, suggesting that the acylations alone do not
determine the rate of membrane association and that
other features of the unique domains might be important.
One difference between the unique domains of Lck and
Fyn is the presence of two cysteines in Lck (Cys 20 and 23)
that are required for the interaction with the cytoplasmic
domains of CD4 and CD8. However, we excluded a role
for this interaction in membrane-binding kinetics of Lck,
since the kinetics are similar in the presence and absence
of CD4/CD8. Another difference between the unique do-
mains of Lck and Fyn is the absence of positively charged
amino acids in the NH2-terminal 30 residues of Lck, while
five positively charged amino acids are present in the cor-
responding region of Fyn. Given that Src requires posi-
tively charged amino acids for membrane association (Sil-
verman and Resh, 1992), it is possible that these charges in
Fyn also facilitate membrane binding. It is noteworthy that
a mutant Fyn which is myristoylated but not palmitoylated
can associate with membranes to some extent (Alland et al.,
1994; Shenoy-Scaria et al., 1994; Wolven et al., 1997),
whereas the corresponding Lck mutant does not (Kwong
and Lublin, 1995; Yurchak and Sefton, 1995; Bijlmakers
et al., 1997; Zlatkine et al., 1997). This implies that, in con-
trast to Lck, newly synthesized, myristoylated Fyn might
have some affinity for membranes and as a result may
translocate faster to membranes than Lck. van’t Hof and
Resh (1997) showed that NH2-terminal amino acid substi-
tutions, apart from the myristoylation and palmitoylation
sites at Gly 2 and Cys 3, respectively, did not change mem-
brane-binding rates for Fyn. However, all their reported
mutants contained at least one positively charged amino
acid in the NH2-terminal 10 residues.
The interaction of newly synthesized Lck with CD4 oc-
curred with similar kinetics to its interaction with mem-
branes (Figs. 2 and 5). CD4 binding must succeed mem-
brane association since nonpalmitoylated Lck is unable to
associate with CD4 (Turner et al., 1990). Consistent with
Figure 8. Transport of CD4-associated Lck is inhibited in the presence of BFA. (A) SupT1 cells were labeled in the absence or presence
of BFA. BFA was added 2 min before pulse-labeling at a concentration of 10 mg/ml and was present during the chase at 2 mg/ml. Cell
surface (CS) and intracellular (IC) CD4 were immunoprecipitated separately as described for Fig. 7. (B) Quantitation of the autoradio-
gram in A for Lck. Per time point, the amount of Lck associated with cell surface (CS) CD4 was expressed as a percentage of the total
(CS 1 IC) Lck coimmunoprecipitated with CD4. Black bars, without BFA; striped bars, with BFA. (C) Quantitation of the autoradio-
gram in A for CD4. Per time point the relative amount of CD4 detected in the cell surface (CS) immunoprecipitation was expressed as
a percentage of the total (CS 1 IC) amount of CD4. Black bars, without BFA; striped bars, with BFA.The Journal of Cell Biology, Volume 145, 1999 466
this, we observed the earliest CD4 association of Lck
shortly after the earliest detectable membrane association
(Fig. 5). This suggests that CD4 binding follows rapidly
upon membrane binding, and therefore upon palmitoyla-
tion of Lck. Thus, it is likely that all three events (palmi-
toylation, membrane binding, and CD4 binding) occur at
the same location in the cell. While we have no direct data
concerning the site where palmitoylation or initial mem-
brane association occurs, several results suggest that the
initial interaction with CD4 takes place on an early com-
partment of the exocytic pathway. First, the association of
newly synthesized CD4 with Lck starts within 10 min of
CD4 synthesis (Fig. 6 A), at a time when CD4 has not yet
reached the plasma membrane and is located in the exo-
cytic pathway (Fig. 6 B). Secondly, newly synthesized Lck
associates initially with intracellular CD4 and only at later
times (after 40 min of chase) with cell surface CD4 (Fig.
7). Thirdly, in the presence of BFA, transport of CD4-
associated Lck to the plasma membrane was inhibited
(Fig. 8). Previously, Crise and Rose (1992a) showed that
Lck can interact with CD4 retained in the ER. Interaction
at the ER was also found in cells overexpressing both Lck
and a chimera containing the VSV G protein ectodomain
and the cytoplasmic tail of CD4 (Shaw et al., 1989). How-
ever, in these latter experiments the CD4 construct resides
in the ER for a long time, at least 60 min after synthesis
(Shaw et al., 1989). The pulse–chase experiments de-
scribed here show that the interaction of CD4 with Lck
takes place early in the exocytic pathway irrespective
of expression levels or mislocalizations of CD4 and/or
Lck. Our previous immunofluorescence experiments with
transfected HeLa cells indicate that CD4 and Lck can in-
teract at the Golgi complex and travel to the plasma mem-
brane together (Bijlmakers et al., 1997). Thus, the normal
route for the bulk of newly synthesized Lck is initial asso-
ciation with intracellular CD4 followed by delivery to the
plasma membrane. The BFA experiments (Figs. 8 and 9
A) support this conclusion and further indicate that newly
synthesized Lck associates with CD4 at a compartment lo-
cated before the TGN (Klausner et al., 1992).
The ability of newly synthesized CD4 to associate with
Lck in the presence of BFA (Fig. 9 A) and the observation
that Endo H–sensitive CD4 coimmunoprecipitates with
Lck (not shown) suggest that Lck can associate with mem-
branes of the ER or intermediate compartment. Since
palmitoylation is required for stable membrane associa-
tion of Lck, our results imply that palmitoylation of newly
synthesized Lck occurs on intracellular membranes of the
early exocytic pathway. To date, palmitoyl transferase ac-
tivity has been detected at the plasma membrane (Dunphy
et al., 1996; Schroeder et al., 1996), intermediate compart-
ment (Bonatti et al., 1989), Golgi complex (Solimena et al.,
1994; Dunphy et al., 1996), and mitochondria (Dunphy et al.,
1996). Palmitoyl transferase activities have been partially
purified (Berthiaume and Resh, 1995; Dunphy et al., 1996;
Liu et al., 1996), but the number of different palmitoyl
transferases in the cell, their specificities, and subcellular
distributions are unknown. Several transmembrane pro-
teins are palmitoylated early after synthesis in the ER or
intermediate compartment (Bonatti et al., 1989; Veit and
Schmidt, 1993) and the cytosolic GAD65 (Solimena et al.,
1994) requires targeting to the Golgi for palmitoylation.
Possibly, newly synthesized Lck uses the same palmitoyl
transferase(s) as these proteins. Palmitoylation of two cy-
tosolic proteins, SNAP25 and GAP43, is inhibited by
BFA, suggesting that an intact secretory pathway is re-
quired for the palmitoylation of these proteins (Gonzalo
and Linder, 1998). On the other hand, palmitoylation of
several viral transmembrane proteins is not affected by
BFA (Veit and Schmidt, 1993; Uleato et al., 1995). Also
for Lck, palmitoylation in the presence of BFA is appar-
ently normal since membrane-binding kinetics (Fig. 9 B)
and palmitic acid incorporation (not shown) were unaf-
fected. Currently, there are no direct data concerning the
cellular sites of palmitoylation of Src-family proteins. It
has been suggested that this modification can occur at the
plasma membrane since a short fluorescent peptide con-
taining the first three amino acids of Lck (myrGlyCysGly)
is palmitoylated and incorporates into the plasma mem-
brane when added to intact cells (Schroeder et al., 1996).
Palmitoylation of Lck is reversible (Paige et al., 1993), sug-
gesting that the protein undergoes cycles of de-palmitoyla-
tion and re-palmitoylation. The re-palmitoylation might
well occur at the plasma membrane where most steady-
state Lck is located. However, the experiments described
here indicate that newly synthesized Lck is palmitoylated
on early membranes of the exocytic pathway.
The delivery of Lck from an intracellular membrane
compartment to the plasma membrane in a BFA-sensitive
Figure 9. Binding of Lck to newly synthesized CD4 and mem-
branes in the presence of BFA. (A) SupT1 cells were pulse-labeled
for 5 min and chased for 40 min in the absence or presence of
BFA (10 mg/ml during pulse, 2 mg/ml during chase). Pretreat-
ment with BFA was 2 min before the pulse. NP-40 cell lysates
were subjected to immunoprecipitation, first with anti-Lck (aLck
lanes), next with anti-CD4 antibodies (aCD4). Lck, CD4, and a
background band (w) are indicated. (B) SupT1 cells were pre-
treated and labeled for 5 min in the presence of BFA (10 mg/ml)
and chased for indicated times in the presence of 2 mg/ml BFA.
Lck was immunoprecipitated at indicated chase times from mem-
brane (M) and soluble (S) fractions.Bijlmakers and Marsh Trafficking of p56lck 467
manner presents a novel transport route for an acylated,
cytosolic protein. The routes of only two other acylated
proteins have been studied: Fyn which is myristoylated
and palmitoylated, and the Gag protein of Moloney mu-
rine leukemia virus, which is myristoylated only. In con-
trast to Lck, both of these proteins were found to be tar-
geted to the plasma membrane directly (Suomalainen et al.,
1996; van’t Hof and Resh, 1997). Fyn resembles Lck in the
nature of its acylations, its expression in T lymphocytes,
and its role in signaling through the TcR. However, while
Lck interacts with CD4 and/or CD8 (Rudd et al., 1988;
Veillette et al., 1988), no high stoichiometry interactions
with transmembrane proteins have been identified for
Fyn. Although expression of CD4 and CD8 does not affect
steady-state localization nor membrane-binding kinetics
of Lck, these proteins could still influence the transport
route of Lck. If, for instance, newly synthesized CD4/CD8
is the only pool capable of interacting with Lck, targeting
of Lck to early exocytic compartments would be required
to facilitate efficient assembly of the coreceptor–Lck com-
plexes. Possibly, Lck contains intrinsic signals for target-
ing to an intracellular membrane compartment. Alterna-
tively, the presence of available CD4/CD8 might recruit
newly synthesized Lck to early exocytic compartments and
thereby favor palmitoylation and membrane association at
these sites. Newly synthesized, nonpalmitoylated Lck is lo-
cated primarily in the cytosol and shows no stable interac-
tion with CD4. However, a weak interaction might occur
since soluble Lck associates with CD4 in the yeast two-
hybrid system (Campbell et al., 1995) and when coex-
pressed in Escherichia coli (Huse et al., 1998). Determin-
ing the precise site(s) of the initial Lck interaction with
membranes and the influence of CD4/CD8 in defining this
site will require further analysis. Nevertheless, the experi-
ments reported here indicate that palmitoylation of Lck
occurs on intracellular membranes and that Lck is trans-
ported to the plasma membrane via the exocytic pathway.
Further characterization of the cellular and molecular
mechanisms that underlie this transport will be essential
for understanding the properties and functions of acylated
proteins.
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